Switch theme
Sign up to access all valuation multiples
JZJ Chain Drugstore Corp is engaged in the retail chain business of health products such as medicines, health foods, personal care products, household health products, convenience foods, and daily consumables and provides related professional services.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
JZJ Chain Drugstore has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, JZJ Chain Drugstore achieved revenue of $1.3B and an EBITDA of $192M.
JZJ Chain Drugstore expects next 12-month revenue of XXX and NTM EBITDA of XXX
See JZJ Chain Drugstore valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.3B | n/a | XXX | XXX | XXX |
| Gross Profit | $258M | $374M | XXX | XXX | XXX |
| Gross Margin | 21% | NaN% | XXX | XXX | XXX |
| EBITDA | $192M | n/a | XXX | XXX | XXX |
| EBITDA Margin | 15% | NaN% | XXX | XXX | XXX |
| Net Profit | $41.4M | $50.1M | XXX | XXX | XXX |
| Net Margin | 3% | NaN% | XXX | XXX | XXX |
| Net Debt | n/a | $63.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, JZJ Chain Drugstore's stock price is CNY 20 (or $3).
JZJ Chain Drugstore has current market cap of CNY 3.2B (or $436M), and EV of CNY 6.6B (or $907M).
See JZJ Chain Drugstore trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $907M | $436M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, JZJ Chain Drugstore has market cap of $436M and EV of $907M.
JZJ Chain Drugstore's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate JZJ Chain Drugstore's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for JZJ Chain Drugstore and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $907M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpJZJ Chain Drugstore's NTM/LTM revenue growth is n/a
JZJ Chain Drugstore's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, JZJ Chain Drugstore's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate JZJ Chain Drugstore's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for JZJ Chain Drugstore and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 28% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JZJ Chain Drugstore acquired XXX companies to date.
Last acquisition by JZJ Chain Drugstore was XXXXXXXX, XXXXX XXXXX XXXXXX . JZJ Chain Drugstore acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was JZJ Chain Drugstore founded? | JZJ Chain Drugstore was founded in 2004. |
| Where is JZJ Chain Drugstore headquartered? | JZJ Chain Drugstore is headquartered in China. |
| Is JZJ Chain Drugstore publicy listed? | Yes, JZJ Chain Drugstore is a public company listed on SHG. |
| What is the stock symbol of JZJ Chain Drugstore? | JZJ Chain Drugstore trades under 605266 ticker. |
| When did JZJ Chain Drugstore go public? | JZJ Chain Drugstore went public in 2020. |
| Who are competitors of JZJ Chain Drugstore? | Similar companies to JZJ Chain Drugstore include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of JZJ Chain Drugstore? | JZJ Chain Drugstore's current market cap is $436M |
| Is JZJ Chain Drugstore profitable? | Yes, JZJ Chain Drugstore is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
